Skip Navigation
Polsinelli's logo
  • Search
  • Our People
  • Our Capabilities
  • About Us
  • Alumni Network
  • Careers
  • Insights
    • News
    • Publications
    • Events
    • Blogs & Podcasts
  • Offices & Locations
  • Our Diverse Culture
  • Client Login
  • Contact Us

Jose J. Jimenez

Shareholder
he / him / his
  • Biography
  • Matters
  • Publications

Publications

July 14, 2023 Publications
Designing the Future: Protecting AR/VR Innovations With Design Patents
Co-Author, New York Law Journal
January 02, 2023 Publications
Where Key Patent Policy Issues Stand In 2023
Quoted, Law360
December 12, 2022 Publications
Legal Education Series - Patent 101
Presenter, TRTCLE
Biography
Matters
Publications
Firm Highlights
Slide 1 of 5
  • News
    Polsinelli Bolsters Public Policy Practice with Senior Policy Advisor Eli Greenspan
    Polsinelli is pleased to announce that Eli Greenspan has joined the firm as a senior policy advisor in its Public Policy Practice in Washington, D.C. 
    Read more
  • Event
    AI Risk Management: Navigating Cybersecurity and Privacy Compliance
    As part of our Digital Risk and Innovation Summit Series, join Polsinelli for this webinar that will explore the key cybersecurity and privacy issues associated with AI.
    Read more
  • News
    Polsinelli Earns Firm and Attorney Recognitions in 2026 IP STARS
    Polsinelli is pleased to announce that the firm and 13 attorneys from its Intellectual Property Practice have been recognized in the 2026 edition of IP STARS, published by Managing IP.
    Read more
  • Publication
    Rise in IP Litigation Brings Patent vs. Trade Secret Strategy Back Into Focus
    Patent and trade secret protection solve different IP strategy problems, with patents generally fitting inventions likely to be disclosed and trade secrets generally fitting information that can remain confidential.
    Read more
  • Publication
    CMS, FDA Propose RAPID Pathway for Medicare Coverage of Certain Medical Devices
    The proposed RAPID pathway would create a new voluntary CMS/FDA process for certain innovative medical devices, with the stated goals of expediting Medicare coverage, improving efficiency and supporting patient access.
    Read more
Follow us on LinkedInFollow us on Instagram
© 2026 Polsinelli. Attorney Advertising.
Prior results do not guarantee a similar outcome.
Contact UsSubscribeAlumni NetworkCollaborate PolsinelliClient Payment PortalDisclaimerCookie PreferencesPrivacy Notice